FAQs
Frequently Asked Questions
Alzheimer’s disease is complex, and the science around it moves quickly. These answers draw on the National Institute on Aging, the Centers for Disease Control and Prevention, and the Alzheimer’s Association, and each is traceable to the sources listed at the end of this page.
This page is awaiting client confirmation. The statistics carry their own as-of dates, several from 2025 and 2026 sources, and no schedule for re-checking them has been agreed.
The Basics
About the Disease
There are several types of age-related dementia. Common diagnoses are Frontotemporal Dementia; Lewy Body Dementia; Vascular Dementia; and Alzheimer’s Disease. Alzheimer’s is the most common cause of dementia in older adults.
Alzheimer’s is a progressive neurodegenerative disorder characterized by a loss of cognitive and behavioral abilities and function. It slowly destroys memory and thinking skills and, eventually, the ability to carry out simple tasks and care for oneself.
There are some treatments that may slow progression of the disease in some people or improve the quality of life of some patients, but there is no known cure.
The disease is named after Dr. Alois Alzheimer. In 1906, he found the physical abnormalities that define Alzheimer’s disease when he conducted a post-mortem examination of the brain tissue of a woman who had died of an unusual mental illness and whose symptoms had included memory loss, language problems and erratic behavior.
Alzheimer’s disease remains one of the most significant public health challenges in the United States and worldwide. It is the seventh leading cause of death in the United States and the sixth leading cause of death in adults 65 years or older. The number of reported Alzheimer’s deaths doubled between 2000 and 2025.
In the United States, more than seven million people age 65+ years live with the disease and, absent a medical breakthrough, is on track to grow to 13.8 million by 2060. Globally, the number of people 65+ years with Alzheimer’s and related dementias increased by 160% between 1991 and 2021, and the number is projected to increase another 50% by 2050. Alzheimer’s disproportionately affects older adults and women; and estimates indicate that half of people living with Down syndrome will develop the disease, with symptoms usually appearing as early as their 40s. After age 60, the risk of developing Alzheimer’s doubles every five years.
The total annual cost of caring for people living with Alzheimer’s and other dementias (excluding unpaid care) is projected to be $384 billion in 2025; and nearly 12 million family members and friends provide 19.2 billion hours of unpaid care, valued to be an additional $413 billion. More than half of caregivers report high stress, and more than 20% leave their jobs. By 2031, there is expected to be a shortage of one million workers needed as caregivers.
Causes and Risk
What Causes Alzheimer’s Disease or Contributes to the Risk of Getting It?
Alzheimer’s disease is defined by abnormal clumps of protein deposits in the brain called amyloid plaques and tangled bundles of fibers in the brain called neurofibrillary or “tau” tangles. These are complex changes in the brain that begin long before symptoms appear. But why do plaques and tangles develop? We don’t yet know, but scientists suspect that several factors could play a role, although the significance of any particular risk factor appears to vary significantly from person to person. Factors associated with Alzheimer’s risk include:
Age. Alzheimer’s disease is not a “normal” part of the aging process; however, most people diagnosed with it are 65 years of age or older. About one in 13 people between 64 to 84, and about one in three people 85 and older, live with Alzheimer’s disease. And, although less common, Alzheimer’s symptoms can appear as early as the mid-40s (known as “early-onset Alzheimer’s disease”). Scientists do not yet know how age contributes to the damage to the brain that results in Alzheimer’s, but they are exploring a number of possibilities, including the shrinking of certain brain regions, inflammation, blood vessel damage, production of unstable molecules called free radicals, and mitochondrial dysfunction (a breakdown of energy production within a cell).
Genetics. “Genetic variants” are inherited permanent changes in one or more genes. Some genetic variants are strong predicters that a person will in fact develop a particular disease; others merely increase or decrease the risk of developing that disease. Researchers have found at least 75 genetic variants associated with Alzheimer’s risk. The vast majority of Alzheimer’s disease appears to develop as a result of multiple gene variants combined with other risk factors, and not by a single variant.
The apolipoprotein E (“APOE”) gene, which provides the blueprint for a protein that transports cholesterol in the bloodstream, is one of the genes associated with Alzheimer’s, but different forms (or “alleles”) of the gene impact the risk quite differently. For instance, the allele identified as APOEe2 is believed to provide some protection against Alzheimer’s and APOEe3 (the most common allele) is believed to have a neutral effect; but research indicates that an APOEe4 gene increases the risk of developing late-onset Alzheimer’s (and two copies of it create a higher risk than one) and, in some populations, is associated with early-onset Alzheimer’s. However, some people with the APOEe4 gene never develop Alzheimer’s, and genetic ancestry (i.e., the geographical region of biological descent) appears to affect the risk, as well.
Among the known genetic variants currently associated with Alzheimer’s, there are three extremely rare single gene variants believed to cause the disease: amyloid precursor protein (“APP”); presenilin1 (“PSEN1”); and presenilin2 (“PSEN2”). An estimated 1% or less of people living with Alzheimer’s are believed to carry these variants, but if a person inherits one of them, early-onset Alzheimer’s is a strong probability. And, people with Down syndrome are at higher risk than the general population because they have an extra copy of the chromosome (chromosome 21) that carries the APP gene.
Family History. Family history is not a definitive predicter. However, people with a first-degree relative (parent or sibling) who had or have the disease are at greater risk, and those with multiple first-degree relatives who had or have the disease are at even greater risk. When a disease runs in a family, both heredity and non-genetic factors may play a role.
Traumatic Brain Injury. A history of concussions and other traumatic brain injuries may also increase the risk of an Alzheimer’s diagnosis.
Lifestyle and Environment. Some researchers suspect that Alzheimer’s risk may increase as a result of various lifestyle and environmental factors, such as unmanaged chronic health issues (including high blood pressure, obesity, and heart disease), hearing loss, depression, physical inactivity, lack of mental stimulation, unhealthy diet, alcohol misuse, smoking, poor sleep hygiene, social isolation, and exposure to pollutants and toxins. Studies also have shown a correlation between higher rates of dementia, on the one hand, and inadequate access to resources and other socioeconomic factors, on the other.
Progression
What Are the Stages of Alzheimer’s and the Associated Symptoms?
Changes in the brain can begin a decade or more before symptoms appear. During the very early stages, healthy neurons can stop functioning, die or lose connections with other neurons. The damage initially appears to take place in the hippocampus and entorhinal cortex – parts of the brain that are essential to forming memories. As the disease progresses, it affects other parts of the brain and, by the final stage of the disease, brain tissue has substantially decreased and atrophied, resulting in dramatic impairment of functionality.
Early-Stage. Typically, memory impairment is one of the first signs of cognitive impairment associated with Alzheimer’s. Other symptoms can include vision/spatial issues, impaired reasoning or judgment, and word-finding difficulties.
Mild Stage. As the disease progresses, memory loss and cognitive difficulties increase. As this stage sets in, people may start wandering and getting lost, repeat questions, have trouble handling money and finances, take longer to complete daily tasks, and exhibit disturbing personality and behavioral changes. The disease is frequently diagnosed at this stage.
Moderate Stage. This stage is characterized by further deterioration in behavior and cognition as damage spreads to areas of the brain that control language, reasoning, conscious thought and sensory processing. Memory loss and confusion worsen. Recognizing family and friends, learning new things, and completing multi-step tasks (like getting dressed) become challenges. At this stage, people may act impulsively and experience delusions, paranoia and hallucinations.
Severe or Late-Stage. Eventually, plaques and tangles have spread throughout the brain, and brain tissue has markedly shrunk. Communication is impossible, the patient is totally dependent on others for care, and the body completely shuts down.
Diagnosis
Diagnosis and Prognosis
There is no blood test, brain scan or other single test to definitively diagnose Alzheimer’s; and genetic testing is not routinely used by clinicians because results do not conclusively predict whether or not a person will develop the disease. Instead, doctors use a combination of physical exams, mental tests and other diagnostic tools.
It varies widely. Studies indicate that people 65 years and older live an average of four to eight years after receiving an Alzheimer’s diagnosis, although some patients survive as long as 20 years after diagnosis.
Our Research
There is no cure today. Our work is a genetics-based effort to change that, beginning with a Phase I proof-of-concept study.
Citations
Sources
NIH National Institute on Aging, Infographic: Understanding Different Types of Dementia, <https://www.nia.nih.gov/health/alzheimers-and-dementia/understanding-different-types-dementia> (last visited July 2, 2026).
NIH National Institute on Aging, Alzheimer’s and Dementia, <https://www.nia.nih.gov/health/alzheimers-and-dementia> (last visited July 2, 2026).
NIH National Institute on Aging, What is Alzheimer’s Disease? <https://www.nia.nih.gov/health/alzheimers-and-dementia/what-alzheimers-disease> (last visited July 2, 2026).
NIH National Institute on Aging, Understanding Alzheimer’s Disease Genes, NIH Publication No. 24-AG-8202, <https://order.nia.nih.gov/publication/understanding-alzheimers-disease-genes> (last visited July 2, 2026).
NIH National Institute on Aging, What are the Signs of Alzheimer’s Disease? <https://www.nia.nih.gov/health/alzheimers-symptoms-and-diagnosis/what-are-signs-alzheimers-disease> (last visited July 2, 2026).
NIH National Institute on Aging, Alzheimer’s Disease Fact Sheet, <https://www.nia.nih.gov/health/alzheimers-and-dementia/alzheimers-disease-fact-sheet> (last visited July 2, 2026).
NIH National Institute on Aging, 2025 NIH Alzheimer’s Disease and Related Dementias Research Progress Report: Advances and Achievements, <https://www.nia.nih.gov/about/2025-nih-dementia-research-progress-report> (last visited July 2, 2026).
NIH National Institute on Aging, How Alzheimer’s Changes the Brain, <https://www.youtube.com/watch?v=hEw1Yq_4PaA> (last visited July 2, 2026).
U.S. Centers for Disease Control and Prevention, Alzheimer’s Disease and Dementia, Dementia, <https://www.cdc.gov/alzheimers-dementia/about/alzheimers.html> (Aug. 15, 2024).
U.S. Centers for Disease Control and Prevention, Signs and Symptoms of Dementia, <https://www.cdc.gov/alzheimers-dementia/signs-symptoms/index.html> (Aug. 14, 2024).
Alzheimer’s.gov, Can I Prevent Dementia? <https://www.alzheimers.gov/life-with-dementia/can-i-prevent-dementia> (last updated June 16, 2026).
Alzheimer’s.gov, What is Alzheimer’s Disease? <https://www.alzheimers.gov/alzheimers-dementias/alzheimers-disease> (last updated June 7, 2026).
Alzheimer’s Association, New Alzheimer’s Association Report: Americans Want Early Diagnosis, Treatment and Are Open to Risk-Taking to Slow Disease Progression, <https://www.alz.org/news/2025/facts-figures-report-alzheimers-treatment> (Apr. 29, 2025).
Alzheimer’s Association, 2025 Alzheimer’s Disease Facts and Figures, <https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.70235> (Apr. 29, 2025; updated June 2, 2025).
Alzheimer’s Association, 2026 Alzheimer's Disease Facts and Figures, <https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf> (last visited Aug. 3, 2026).
Alzheimer’s Association AAIC Press Release, Research Advances from the 2025 Alzheimer’s Association International Conference, <https://aaic.alz.org/releases-2025/highlights-aaic-2025.asp> (July 31, 2025).
North American Community Hub Statistics, Alzheimer’s Disease in the US – 2025 Facts and Figures, <https://nchstats.com/alzheimers-disease-in-the-us/> (last visited July 2, 2026).